These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 23474289)
1. Roles of the epoxygenase CYP2J2 in the endothelium. Askari A; Thomson SJ; Edin ML; Zeldin DC; Bishop-Bailey D Prostaglandins Other Lipid Mediat; 2013 Dec; 107():56-63. PubMed ID: 23474289 [TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. Deng Y; Theken KN; Lee CR J Mol Cell Cardiol; 2010 Feb; 48(2):331-41. PubMed ID: 19891972 [TBL] [Abstract][Full Text] [Related]
3. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response. Nayeem MA; Geldenhuys WJ; Hanif A Adv Pharmacol; 2023; 97():37-131. PubMed ID: 37236764 [TBL] [Abstract][Full Text] [Related]
4. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids. Shahabi P; Siest G; Visvikis-siest S Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964 [TBL] [Abstract][Full Text] [Related]
5. CYP450 Epoxygenase Metabolites, Epoxyeicosatrienoic Acids, as Novel Anti-Inflammatory Mediators. Shi Z; He Z; Wang DW Molecules; 2022 Jun; 27(12):. PubMed ID: 35744996 [TBL] [Abstract][Full Text] [Related]
6. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Xu X; Zhang XA; Wang DW Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response. Nayeem MA; Hanif A; Geldenhuys WJ; Agba S Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366 [TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acid pathway in human health and diseases. Bellien J; Joannides R J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice. Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of epoxyeicosatrienoic acids. Thomson SJ; Askari A; Bishop-Bailey D Int J Vasc Med; 2012; 2012():605101. PubMed ID: 22848834 [TBL] [Abstract][Full Text] [Related]
12. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids. Karkhanis A; Tram NDT; Chan ECY Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841 [TBL] [Abstract][Full Text] [Related]
13. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells. Yang B; Graham L; Dikalov S; Mason RP; Falck JR; Liao JK; Zeldin DC Mol Pharmacol; 2001 Aug; 60(2):310-20. PubMed ID: 11455018 [TBL] [Abstract][Full Text] [Related]
15. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation. Fleming I Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757 [TBL] [Abstract][Full Text] [Related]
16. CYP epoxygenase derived EETs: from cardiovascular protection to human cancer therapy. Chen C; Wang DW Curr Top Med Chem; 2013; 13(12):1454-69. PubMed ID: 23688135 [TBL] [Abstract][Full Text] [Related]